HDFC Nifty Midcap 150 Index Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
6,809 sh · ₹1.81 Cr
SBI Midcap Fund
1.3% of their portfolio
₹318.65 Cr
12,00,000 sh
Nippon India Pharma Fund
2.7% of their portfolio
₹246.64 Cr
9,28,841 sh
Nippon India Growth Mid Cap Fund
0.3% of their portfolio
₹148.44 Cr
5,59,000 sh
SBI Dividend Yield Fund
1.4% of their portfolio
₹119.49 Cr
4,50,000 sh
ICICI Prudential Smallcap Fund
0.6% of their portfolio
₹55.76 Cr
2,10,000 sh
Aditya Birla Sun Life MNC Fund
1.4% of their portfolio
₹46.41 Cr
1,89,399 sh
Aditya Birla Sun Life Multi-Cap Fund
0.3% of their portfolio
₹24.50 Cr
1,00,000 sh
Aditya Birla Sun Life ELSS Tax Saver Fund
0.1% of their portfolio
₹11.59 Cr
49,585 sh
Nippon India ETF Nifty Midcap 150
0.3% of their portfolio
₹9.86 Cr
37,134 sh
Aditya Birla Sun Life Pharma & Healthcare Fund
0.8% of their portfolio
₹7.94 Cr
32,390 sh
Nippon India Nifty Midcap 150 Index Fund
0.3% of their portfolio
₹7.22 Cr
27,176 sh
ICICI Prudential Nifty Midcap 150 Index Fund
0.3% of their portfolio
₹3.33 Cr
12,527 sh
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
HDFC Nifty Midcap 150 Index Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
6,809 sh · ₹1.81 Cr
Groww Mutual Fund (scheme VD)
GlaxoSmithKline Pharmaceuticals Limited · NSE
2,320 sh · ₹61.61 L
ICICI Prudential Nifty LargeMidcap 250 Index Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
1,459 sh · ₹38.74 L
Groww Mutual Fund (scheme YD)
GlaxoSmithKline Pharmaceuticals Limited · NSE
147 sh · ₹3.90 L
Nippon India Nifty 500 Equal Weight Index Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
4,266 sh · ₹1.13 Cr
SBI Nifty Midcap 150 Index Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
12,012 sh · ₹3.19 Cr
Nippon India Growth Mid Cap Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
5,59,000 sh · ₹148.44 Cr
ICICI Prudential Quant Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
12,022 sh · ₹3.19 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
31 announcements on record for this company.
Promoter holding by quarter: Jun 2025 75.0%, Sep 2025 75.0%, Dec 2025 75.0%, Mar 2026 75.0%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— 0.0pp
FII holding by quarter: Jun 2025 4.9%, Sep 2025 4.8%, Dec 2025 4.6%, Mar 2026 4.6%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 7.7%, Sep 2025 7.8%, Dec 2025 7.7%, Mar 2026 7.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— 0.0pp
MF holding by quarter: Jun 2025 5.2%, Sep 2025 5.0%, Dec 2025 4.8%, Mar 2026 4.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
ICICI Prudential MNC Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
7,662 sh · ₹2.03 Cr
ICICI Prudential Nifty 500 Index Fund
GlaxoSmithKline Pharmaceuticals Limited · NSE
201 sh · ₹5.34 L
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 75.0%, Sep 2025 75.0%, Dec 2025 75.0%, Mar 2026 75.0%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— 0.0pp
FII holding by quarter: Jun 2025 4.9%, Sep 2025 4.8%, Dec 2025 4.6%, Mar 2026 4.6%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 7.7%, Sep 2025 7.8%, Dec 2025 7.7%, Mar 2026 7.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— 0.0pp
MF holding by quarter: Jun 2025 5.2%, Sep 2025 5.0%, Dec 2025 4.8%, Mar 2026 4.7%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
31 announcements on record for this company.